Acknowledgement
We would like to thank Sang Yong Sim, RN (Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center) for assistance with the study.
References
- Choi H, Yang B, Nam H, Kyoung DS, Sim YS, Park HY, et al. Population-based prevalence of bronchiectasis and associated comorbidities in South Korea. Eur Respir J 2019;54:1900194. https://doi.org/10.1183/13993003.00194-2019
- Kim C, Kim DG. Bronchiectasis. Tuberc Respir Dis 2012;73:249-57. https://doi.org/10.4046/trd.2012.73.5.249
- Seitz AE, Olivier KN, Adjemian J, Holland SM, Prevots DR. Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007. Chest 2012;142:432-9. https://doi.org/10.1378/chest.11-2209
- Ringshausen FC, de Roux A, Pletz MW, Hamalainen N, Welte T, Rademacher J. Bronchiectasis-associated hospitalizations in Germany, 2005-2011: a population-based study of disease burden and trends. PLoS One 2013;8:e71109. https://doi.org/10.1371/journal.pone.0071109
- Ringshausen FC, de Roux A, Diel R, Hohmann D, Welte T, Rademacher J. Bronchiectasis in Germany: a population-based estimation of disease prevalence. Eur Respir J 2015;46:1805-7. https://doi.org/10.1183/13993003.00954-2015
- Quint JK, Millett ER, Joshi M, Navaratnam V, Thomas SL, Hurst JR, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur Respir J 2016;47:186-93. https://doi.org/10.1183/13993003.01033-2015
- Yang B, Choi H, Lim JH, Park HY, Kang D, Cho J, et al. The disease burden of bronchiectasis in comparison with chronic obstructive pulmonary disease: a national database study in Korea. Ann Transl Med 2019;7:770. https://doi.org/10.21037/atm.2019.11.55
- Choi H, Yang B, Kim YJ, Sin S, Jo YS, Kim Y, et al. Increased mortality in patients with non cystic fibrosis bronchiectasis with respiratory comorbidities. Sci Rep 2021;11:7126. https://doi.org/10.1038/s41598-021-86407-8
- Sin S, Yun SY, Kim JM, Park CM, Cho J, Choi SM, et al. Mortality risk and causes of death in patients with non-cystic fibrosis bronchiectasis. Respir Res 2019;20:271. https://doi.org/10.1186/s12931-019-1243-3
- Lee H, Choi H, Chalmers JD, Dhar R, Nguyen TQ, Visser SK, et al. Characteristics of bronchiectasis in Korea: first data from the Korean Multicentre Bronchiectasis Audit and Research Collaboration registry and comparison with other international registries. Respirology 2021;26:619-21. https://doi.org/10.1111/resp.14059
- Dhar R, Singh S, Talwar D, Mohan M, Tripathi SK, Swarnakar R, et al. Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry. Lancet Glob Health 2019;7:e1269-79. https://doi.org/10.1016/S2214-109X(19)30327-4
- McShane PJ, Naureckas ET, Tino G, Strek ME. Noncystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2013;188:647-56. https://doi.org/10.1164/rccm.201303-0411CI
- McDonnell MJ, Aliberti S, Goeminne PC, Restrepo MI, Finch S, Pesci A, et al. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study. Lancet Respir Med 2016;4:969-79. https://doi.org/10.1016/S2213-2600(16)30320-4
- Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn SJ, Floto AR, et al. British Thoracic Society Guideline for bronchiectasis in adults. Thorax 2019;74:1-69.
- Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 2017;50:1700629. https://doi.org/10.1183/13993003.00629-2017
- Gao YH, Guan WJ, Liu SX, Wang L, Cui JJ, Chen RC, et al. Aetiology of bronchiectasis in adults: a systematic literature review. Respirology 2016;21:1376-83. https://doi.org/10.1111/resp.12832
- Amati F, Simonetta E, Pilocane T, Gramegna A, Goeminne P, Oriano M, et al. Diagnosis and initial investigation of bronchiectasis. Semin Respir Crit Care Med 2021;42:513-24. https://doi.org/10.1055/s-0041-1730892
- Dalkey N, Helmer O. An experimental application of the Delphi method to the use of experts. Manag Sci 1963;9:458-67. https://doi.org/10.1287/mnsc.9.3.458
- Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus G. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20. https://doi.org/10.1111/j.1572-0241.2006.00630.x
- Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, et al. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 2012;143:336-46. https://doi.org/10.1053/j.gastro.2012.04.032
- Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J 2016;47:45-68. https://doi.org/10.1183/13993003.00583-2015
- Araujo D, Shteinberg M, Aliberti S, Goeminne PC, Hill AT, Fardon T, et al. Standardised classification of the aetiology of bronchiectasis using an objective algorithm. Eur Respir J 2017;50:1701289. https://doi.org/10.1183/13993003.01289-2017
- Lee H, Choi H, Sim YS, Park S, Kim WJ, Yoo KH, et al. KMBARC registry: protocol for a multicentre observational cohort study on non-cystic fibrosis bronchiectasis in Korea. BMJ Open 2020;10:e034090. https://doi.org/10.1136/bmjopen-2019-034090
- Yang B, Ryu J, Kim T, Jo YS, Kim Y, Park HY, et al. Impact of bronchiectasis on incident nontuberculous mcobacterial pulmonary disease: a 10-year national cohort study. Chest 2021;159:1807-11. https://doi.org/10.1016/j.chest.2020.12.020
- Jose RJ, Loebinger MR. Clinical and radiological phenotypes and endotypes. Semin Respir Crit Care Med 2021;42:549-55. https://doi.org/10.1055/s-0041-1730894
- Aliberti S, Lonni S, Dore S, McDonnell MJ, Goeminne PC, Dimakou K, et al. Clinical phenotypes in adult patients with bronchiectasis. Eur Respir J 2016;47:1113-22. https://doi.org/10.1183/13993003.01899-2015
- Lee H, Oh YM. Clinical approach to non-cystic fibrosis bronchiectasis based on recent clinical guideline. Korean J Med 2020;95:141-50. https://doi.org/10.3904/kjm.2020.95.3.141
- Choi H, Lee H, Ra SW, Oh YM. Update on pharmacotherapy for adult bronchiectasis. J Korean Med Assoc 2020;63:486-92. https://doi.org/10.5124/jkma.2020.63.8.486
- Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, et al. The bronchiectasis severity index: an international derivation and validation study. Am J Respir Crit Care Med 2014;189:576-85. https://doi.org/10.1164/rccm.201309-1575OC
- Lee SY, Lee JS, Lee SW, Oh YM. Effects of treatment with long-acting muscarinic antagonists (LAMA) and long-acting betaagonists (LABA) on lung function improvement in patients with bronchiectasis: an observational study. J Thorac Dis 2021;13:169-77. https://doi.org/10.21037/jtd-20-1282
- Kim JH, Yim JJ. Achievements in and challenges of tuberculosis control in South Korea. Emerg Infect Dis 2015;21:1913-20. https://doi.org/10.3201/eid2111.141894